| Autologous mesenchymal stem cells in chronic stroke A Bhasin, MVP Srivastava, SS Kumaran, S Mohanty, R Bhatia, S Bose, ... Cerebrovascular diseases extra 1 (1), 93-104, 2011 | 187 | 2011 |
| Stem cell therapy: a clinical trial of stroke A Bhasin, MVP Srivastava, S Mohanty, R Bhatia, SS Kumaran, S Bose Clinical neurology and neurosurgery 115 (7), 1003-1008, 2013 | 178 | 2013 |
| Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition R Subramani, E Gonzalez, A Arumugam, S Nandy, V Gonzalez, J Medel, ... Scientific reports 6 (1), 19819, 2016 | 154 | 2016 |
| Role of growth hormone in breast cancer R Subramani, SB Nandy, DA Pedroza, R Lakshmanaswamy Endocrinology 158 (6), 1543-1555, 2017 | 87 | 2017 |
| Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis R Subramani, R Lopez-Valdez, A Arumugam, S Nandy, T Boopalan, ... PloS one 9 (5), e97016, 2014 | 87 | 2014 |
| TGFβ1 contributes to cardiomyogenic-like differentiation of human bone marrow mesenchymal stem cells S Mohanty, S Bose, KG Jain, B Bhargava, BSMSB Airan International journal of cardiology 163 (1), 93-99, 2013 | 87 | 2013 |
| Fibroblast Growth Factor-2 alone as an efficient inducer for differentiation of human bone marrow mesenchymal stem cells into dopaminergic neurons SB Nandy, S Mohanty, M Singh, M Behari, B Airan Journal of biomedical science 21, 1-10, 2014 | 86 | 2014 |
| Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis A Arumugam, P Agullo, T Boopalan, S Nandy, R Lopez, C Gutierrez, ... Cancer biology & therapy 15 (1), 26-34, 2014 | 76 | 2014 |
| MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway N Sushmita Bose, A Arunkumar, S Ramadevi, P Diego, H Keziah, ... Oncotarget, 2015 | 73 | 2015 |
| Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke A Bhasin, MV Srivastava, R Bhatia, S Mohanty, SS Kumaran, S Bose Journal of Stem Cells & Regenerative Medicine 8 (3), 181, 2012 | 66 | 2012 |
| Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR R Lopez, A Arumugam, R Joseph, K Monga, T Boopalan, P Agullo, ... PloS one 8 (11), e79708, 2013 | 61 | 2013 |
| Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2 A Arumugam, R Subramani, SB Nandy, D Terreros, AK Dwivedi, ... Experimental & molecular medicine 51 (1), 1-13, 2019 | 57 | 2019 |
| Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway R Subramani, E Gonzalez, SB Nandy, A Arumugam, F Camacho, J Medel, ... Oncotarget 8 (7), 10891, 2017 | 55 | 2017 |
| Cancer stem cells and metastasis SB Nandy, R Lakshmanaswamy Progress in Molecular Biology and Translational Science 151, 137-176, 2017 | 52 | 2017 |
| Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis R Subramani, L Gangwani, SB Nandy, A Arumugam, M Chattopadhyay, ... International journal of oncology 47 (4), 1203-1210, 2015 | 45 | 2015 |
| Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma R Subramani, R Lopez-Valdez, A Salcido, T Boopalan, A Arumugam, ... Experimental & molecular medicine 46 (10), e117-e117, 2014 | 37 | 2014 |
| Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells SB Nandy, L Gangwani, Z Nahleh, R Subramani, A Arumugam, ... Future Oncology 11 (6), 983-995, 2015 | 29 | 2015 |
| Adipose tissue derived mesenchymal stem cells are better respondents to TGFβ1 for in vitro generation of cardiomyocyte-like cells A Kakkar, SB Nandy, S Gupta, B Bharagava, B Airan, S Mohanty Molecular and Cellular Biochemistry 460, 53-66, 2019 | 28 | 2019 |
| Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis. SB Nandy, A Orozco, R Lopez-Valdez, R Roberts, R Subramani, ... British Journal of Cancer, 2017 | 28 | 2017 |
| Iron oxide labeling does not affect differentiation potential of human bone marrow mesenchymal stem cells exhibited by their differentiation into cardiac and neuronal cells S Mohanty, KG Jain, SB Nandy, A Kakkar, M Kumar, AK Dinda, H Singh, ... Molecular and cellular biochemistry 448, 17-26, 2018 | 22 | 2018 |
Arunkumar ArumugamAssociate Principal Scientist at CBMVerified email at cfbm.com
